Breast Discomfort Supplement Claims Were Poor Fit With Study Findings
This article was originally published in The Rose Sheet
Executive Summary
BioPharmX can support claims its Violet Iodine breast discomfort supplement is designed for women with fibrocystic breast condition, as supported by study data, but must modify claims not specific to the conditions of the women in the study, including those with premenstrual breast discomfort.
You may also be interested in...
NAD Sees Health Claims Without Clinical Trials As Risky But Possible
The National Advertising Division intends its standards and reviews to be flexible but acknowledges it is “risky” for advertisers to support health claims without clinical trial RCT data, says senior attorney Kat Dunnigan.
Consumer Health New Products Roundup
Daily iodine supplementation for premenstrual discomfort; immune system support from Hyperbiotics; Emerald Resources hammers natural in testosterone booster; Cetaphil line reaches babies; SuperNutrition gets HeartSmart; and Iovate Nature’s Food at GNC in U.S.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.